Poughkeepsie Journal editorial: rein in skyrocketing cost of doxycycline and take other actions about Lyme disease.

From the Poughkeepsie Journal editorial board, August 20, 2014:

Whatever the cause, it is abundantly clear something must be done to rein in the skyrocketing costs of the prime antibiotic used against Lyme disease.

In its ongoing investigation about Lyme disease, the Poughkeepsie Journal has reported that the price of doxycycline has climbed at an alarming rate. For instance, 500 pills that once cost about $25 can now cost hundreds of dollars.

Several companies have stopped producing doxycycline and that, in part, could be the reason for the price spike under the laws of supply and demand. While alternatives exist, health experts have said that doxycycline is an optimum treatment.

But this might need a much broader solution from the federal government.

Click here to read the rest of the article.